» Articles » PMID: 24571580

Step Counter Use in Type 2 Diabetes: a Meta-analysis of Randomized Controlled Trials

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2014 Feb 28
PMID 24571580
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Background: While step counter use has become popular among type 2 diabetes (T2D) patients, its effectiveness in increasing physical activity (PA) and improving glycemic control has been poorly defined. The aim of this meta-analysis of randomized controlled trials (RCTs) was to evaluate the association of step counter use with PA and glycemic control in T2D patients.

Methods: Articles were identified by searches of PubMed, Web of Science and Cochrane Library from January 1994 to June 2013. RCTs in the English language were included, if they had assessed the effectiveness of step counters as motivating and monitoring tools in T2D patients, with reported changes in steps per day (steps/d) or glycosylated hemoglobin A1c (HbA1c), or both. Data were independently collected by 2 authors and overall estimates were made by a random-effects model.

Results: Of the 551 articles retrieved, 11 RCTs were included. Step counter use significantly increased PA by 1,822 steps/d (7 studies, 861 participants; 95% confidence interval (CI): 751 to 2,894 steps/d) in patients with T2D. Step counter use with a PA goal showed a bigger increase in PA (weighted mean difference (WMD) 3,200 steps/d, 95% CI: 2,053 to 4,347 steps/d) than without (WMD 598 steps/d, 95% CI: -65 to 1,260 steps/d). Further subgroup analysis suggested step counter use with a self-set PA goal (WMD 2,816 steps/d, 95% CI: 1,288 to 4,344 steps/d) made no difference in increasing PA from a 10,000 steps/d goal (WMD 3,820 steps/d, 95% CI: 2,702 to 4,938 steps/d). However, no significant HbA1c change was observed by step counter use (10 studies, 1,423 participants; WMD 0.02%, 95% CI: -0.08% to 0.13%), either with (WMD 0.04%, 95% CI: -0.21% to 0.30%) or without a PA goal (WMD 0.01%, 95% CI: -0.10% to 0.13%).

Conclusions: Step counter use is associated with a significant increase in PA in patients with T2D. However, evidence regarding its effect in improving glycemic control remains insufficient.

Trial Registration: PROSPERO CRD42013005236.

Citing Articles

Predictors associated with an increase in daily steps among people with prediabetes or type 2 diabetes participating in a two-year pedometer intervention.

Larsson K, Rossen J, Norman A, Johansson U, Hagstromer M BMC Public Health. 2024; 24(1):1290.

PMID: 38734659 PMC: 11088056. DOI: 10.1186/s12889-024-18766-6.


Electronic Interactive Games for Glycemic Control in Individuals With Diabetes: Systematic Review and Meta-Analysis.

Yao W, Han Y, Yang L, Chen Y, Yan S, Cheng Y JMIR Serious Games. 2024; 12:e43574.

PMID: 38345856 PMC: 10897792. DOI: 10.2196/43574.


Wearable Devices to Improve Physical Activity and Reduce Sedentary Behaviour: An Umbrella Review.

Longhini J, Marzaro C, Bargeri S, Palese A, DellIsola A, Turolla A Sports Med Open. 2024; 10(1):9.

PMID: 38219269 PMC: 10788327. DOI: 10.1186/s40798-024-00678-9.


Continuous Monitoring of Health and Mobility Indicators in Patients with Cardiovascular Disease: A Review of Recent Technologies.

Shiwani M, Chico T, Ciravegna F, Mihaylova L Sensors (Basel). 2023; 23(12).

PMID: 37420916 PMC: 10300851. DOI: 10.3390/s23125752.


Use of Wearable Activity-Monitoring Technologies to Promote Physical Activity in Cancer Survivors: Challenges and Opportunities for Improved Cancer Care.

Keats M, Yu X, Sweeney Magee M, Forbes C, Grandy S, Sweeney E Int J Environ Res Public Health. 2023; 20(6).

PMID: 36981693 PMC: 10048707. DOI: 10.3390/ijerph20064784.


References
1.
Snowling N, Hopkins W . Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care. 2006; 29(11):2518-27. DOI: 10.2337/dc06-1317. View

2.
Tahara Y, Shima K . Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care. 1995; 18(4):440-7. DOI: 10.2337/diacare.18.4.440. View

3.
Richardson C, Newton T, Abraham J, Sen A, Jimbo M, Swartz A . A meta-analysis of pedometer-based walking interventions and weight loss. Ann Fam Med. 2008; 6(1):69-77. PMC: 2203404. DOI: 10.1370/afm.761. View

4.
Weinstock R, Brooks G, Palmas W, Morin P, Teresi J, Eimicke J . Lessened decline in physical activity and impairment of older adults with diabetes with telemedicine and pedometer use: results from the IDEATel study. Age Ageing. 2010; 40(1):98-105. DOI: 10.1093/ageing/afq147. View

5.
Bohannon R . Number of pedometer-assessed steps taken per day by adults: a descriptive meta-analysis. Phys Ther. 2007; 87(12):1642-50. DOI: 10.2522/ptj.20060037. View